Drug Discovery and Toxicity Screening

Discovering a new drug is difficult, tedious and expensive process, it can take up-to years and number of failures to develop a new successful drug.  In spite of this, many drugs fail later in the screening processes due to unseen toxic effects and side effects. Hence selection of appropriate models and assays to check on target is necessary to predict the toxicity at early stages and designing new paths in developing new successful drug. Early toxicity screening may help in eliminating the drugs which are not eligible for drug development processes.

 

  • Preclinical Drug Development
  • Preclinical Safety Assessment
  • Toxocological Testing
  • Predictive Toxicology
  • Drug Safety Biomarkers

Related Conference of Drug Discovery and Toxicity Screening

October 04-05, 2018 London, UK

16th Annual Meeting on Environmental Toxicology and Biological Systems

| Park Inn by Radisson Hotel
October 15-16, 2018

16th Global Summit on Toxicology and Applied Pharmacology

Las Vegas, Nevada, USA
October 22-24, 2018

17th Global Toxicology and Risk Assessment Conference

Budapest, Hungary
December 13-14, 2018

19th Annual Conference on Inhalation Toxicology

Dubai, UAE
April 17-18, 2019

Global Summit on Toxicology and Forensic Science

Osaka, Japan

Drug Discovery and Toxicity Screening Conference Speakers

Recommended Sessions

Related Journals

Are you interested in